Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Wall Street
Price Targets
Price Targets Summary
Eyebright Medical Technology Beijing Co Ltd
According to Wall Street analysts, the average 1-year price target for Eyebright Medical Technology Beijing Co Ltd is 227.63 CNY with a low forecast of 175.25 CNY and a high forecast of 279.3 CNY.
Revenue
Forecast
Revenue Estimate
Eyebright Medical Technology Beijing Co Ltd
For the last 4 years the compound annual growth rate for Eyebright Medical Technology Beijing Co Ltd's revenue is 46%. The projected CAGR for the next 3 years is 44%.
Operating Income
Forecast
Operating Income Estimate
Eyebright Medical Technology Beijing Co Ltd
For the last 4 years the compound annual growth rate for Eyebright Medical Technology Beijing Co Ltd's operating income is 86%. The projected CAGR for the next 3 years is 36%.
Net Income
Forecast
Net Income Estimate
Eyebright Medical Technology Beijing Co Ltd
For the last 4 years the compound annual growth rate for Eyebright Medical Technology Beijing Co Ltd's net income is 84%. The projected CAGR for the next 3 years is 32%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Eyebright Medical Technology Beijing Co Ltd's stock price target?
Price Target
227.63
CNY
According to Wall Street analysts, the average 1-year price target for Eyebright Medical Technology Beijing Co Ltd is 227.63 CNY with a low forecast of 175.25 CNY and a high forecast of 279.3 CNY.
What is Eyebright Medical Technology Beijing Co Ltd's Revenue forecast?
Projected CAGR
44%
For the last 4 years the compound annual growth rate for Eyebright Medical Technology Beijing Co Ltd's revenue is 46%. The projected CAGR for the next 3 years is 44%.
What is Eyebright Medical Technology Beijing Co Ltd's Operating Income forecast?
Projected CAGR
36%
For the last 4 years the compound annual growth rate for Eyebright Medical Technology Beijing Co Ltd's operating income is 86%. The projected CAGR for the next 3 years is 36%.
What is Eyebright Medical Technology Beijing Co Ltd's Net Income forecast?
Projected CAGR
32%
For the last 4 years the compound annual growth rate for Eyebright Medical Technology Beijing Co Ltd's net income is 84%. The projected CAGR for the next 3 years is 32%.